Variant report

Variant	esv3406944
Chromosome Location	chr5:37838720-37841568
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:280)
CpG islands
(count:915)
Chromatin interactive
region (count:5)
LncRNA
region (count:5)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:280 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:37840444-37840796	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr5:37839864-37840661	HepG2	liver:	n/a	chr5:37839968-37839984 chr5:37839973-37839989 chr5:37839947-37839963
3	CHD1	chr5:37839012-37839158	H1-hESC	embryonic stem cell:	n/a	n/a
4	CHD1	chr5:37840578-37840766	H1-hESC	embryonic stem cell:	n/a	n/a
5	CHD2	chr5:37840379-37840789	H1-hESC	embryonic stem cell:	n/a	n/a
6	CTBP2	chr5:37839040-37840731	H1-hESC	embryonic stem cell:	n/a	n/a
7	CTCF	chr5:37840660-37840810	WI-38	lung:	n/a	n/a
8	CTCF	chr5:37839940-37840090	BJ	skin:	n/a	n/a
9	CTCF	chr5:37840500-37840650	AG09309	skin:	n/a	n/a
10	CTCF	chr5:37840387-37840605	T-47D	breast:	n/a	n/a
11	CTCF	chr5:37840440-37840590	MCF-7	breast:	n/a	n/a
12	CTCF	chr5:37840200-37840350	GM12865	blood:	n/a	n/a
13	CTCF	chr5:37840480-37840630	AG04449	skin:	n/a	n/a
14	CTCF	chr5:37840407-37840662	MCF-7	breast:	n/a	n/a
15	CTCF	chr5:37840420-37840570	GM12865	blood:	n/a	n/a
16	CTCF	chr5:37840000-37840150	HRE	kidney:	n/a	n/a
17	CTCF	chr5:37840480-37840630	NHDF-neo	bronchial:	n/a	n/a
18	CTCF	chr5:37839980-37840130	HEK293	kidney:	n/a	n/a
19	CTCF	chr5:37836714-37838837	SK-N-SH	brain:	n/a	chr5:37837658-37837679 chr5:37838657-37838670 chr5:37837659-37837672 chr5:37838584-37838597 chr5:37837979-37837992 chr5:37837656-37837674
20	CTCF	chr5:37839870-37840127	IMR90	lung:	n/a	n/a
21	CTCF	chr5:37840420-37840570	BE2_C	brain:	n/a	n/a
22	CTCF	chr5:37840500-37840650	AG04450	lung:	n/a	n/a
23	CTCF	chr5:37840640-37840790	AG10803	skin:	n/a	n/a
24	CTCF	chr5:37840260-37840410	HA-sp	spinal cord:	n/a	n/a
25	CTCF	chr5:37840371-37840759	NHEK	skin:	n/a	n/a
26	CTCF	chr5:37840520-37840670	AG09319	gingival:	n/a	n/a
27	CTCF	chr5:37838760-37838910	HBMEC	blood vessel:	n/a	n/a
28	CTCF	chr5:37839980-37840130	GM12865	blood:	n/a	n/a
29	CTCF	chr5:37840620-37840770	AG09309	skin:	n/a	n/a
30	CTCF	chr5:37838620-37838770	BE2_C	brain:	n/a	chr5:37838657-37838670
31	CTCF	chr5:37840506-37840577	Pancreas_OC	pancreas:	n/a	n/a
32	CTCF	chr5:37840500-37840650	HMF	breast:	n/a	n/a
33	CTCF	chr5:37840438-37840626	MCF-7	breast:	n/a	n/a
34	CTCF	chr5:37840320-37840470	GM12871	blood:	n/a	n/a
35	CTCF	chr5:37840420-37840570	HCM	heart:	n/a	n/a
36	CTCF	chr5:37840406-37840788	Fibrobl	skin:	n/a	n/a
37	CTCF	chr5:37839960-37840110	SAEC	small airway:	n/a	n/a
38	CTCF	chr5:37840360-37840510	GM12872	blood:	n/a	n/a
39	CTCF	chr5:37840460-37840610	AG09319	gingival:	n/a	n/a
40	CTCF	chr5:37839944-37840077	Fibrobl	skin:	n/a	n/a
41	CTCF	chr5:37840422-37840627	A549	lung:	n/a	n/a
42	CTCF	chr5:37840440-37840590	HepG2	liver:	n/a	n/a
43	CTCF	chr5:37840700-37840850	BE2_C	brain:	n/a	n/a
44	CTCF	chr5:37841300-37841450	RPTEC	kidney:	n/a	n/a
45	CTCF	chr5:37839920-37840070	HUVEC	blood vessel:	n/a	n/a
46	CTCF	chr5:37840460-37840610	WI-38	lung:	n/a	n/a
47	CTCF	chr5:37838660-37838810	NHDF-neo	bronchial:	n/a	n/a
48	CTCF	chr5:37840520-37840670	GM12875	blood:	n/a	n/a
49	CTCF	chr5:37839960-37840110	HCFaa	heart:	n/a	n/a
50	CTCF	chr5:37840330-37840854	IMR90	lung:	n/a	n/a

(count:915 , 50 per page) page: 1 2 3 4 5 6 7 ... 19

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:37839407-37839457	AG09319	gingival:	n/a
2	chr5:37839407-37839457	SK-N-SH	brain:	n/a
3	chr5:37840438-37840488	BJ	skin:	n/a
4	chr5:37840725-37840775	HL-60	blood:	n/a
5	chr5:37839943-37839993	HRPEpiC	eye:	n/a
6	chr5:37840438-37840488	Hela-S3	cervix:	n/a
7	chr5:37840839-37840889	Hela-S3	cervix:	n/a
8	chr5:37839684-37839734	AG09319	gingival:	n/a
9	chr5:37840089-37840139	K562	blood:	n/a
10	chr5:37840839-37840889	PANC-1	pancreas:	n/a
11	chr5:37840725-37840775	GM12892	blood:	n/a
12	chr5:37839918-37839968	LNCaP	prostate:	n/a
13	chr5:37840839-37840889	PrEC	prostate:	n/a
14	chr5:37840158-37840208	GM19239	blood:	n/a
15	chr5:37840089-37840139	HCM	heart:	n/a
16	chr5:37840075-37840125	Hepatocyte	liver:	n/a
17	chr5:37840725-37840775	BJ	skin:	n/a
18	chr5:37839829-37839879	NHDF-neo	bronchial:	n/a
19	chr5:37839829-37839879	HCPEpiC	choroid plexus:	n/a
20	chr5:37840725-37840775	GM12891	blood:	n/a
21	chr5:37839829-37839879	Hepatocyte	liver:	n/a
22	chr5:37840089-37840139	GM12878	blood:	n/a
23	chr5:37839918-37839968	IMR90	lung:	fetal
24	chr5:37840075-37840125	ProgFib	skin:	n/a
25	chr5:37839923-37839973	SKMC	muscle:	n/a
26	chr5:37840438-37840488	AG09309	skin:	n/a
27	chr5:37840839-37840889	SK-N-SH	brain:	n/a
28	chr5:37840089-37840139	AG10803	skin:	n/a
29	chr5:37840839-37840889	BE2_C	brain:	n/a
30	chr5:37839829-37839879	NT2-D1	testis:	n/a
31	chr5:37839407-37839457	ProgFib	skin:	n/a
32	chr5:37840089-37840139	GM19239	blood:	n/a
33	chr5:37840438-37840488	RPTEC	kidney:	n/a
34	chr5:37838871-37838921	ovcar-3	ovarian:	n/a
35	chr5:37839407-37839457	SK-N-MC	brain:	n/a
36	chr5:37840438-37840488	U87	brain:	n/a
37	chr5:37840089-37840139	ECC-1	luminal epithelium:	n/a
38	chr5:37840075-37840125	GM12878	blood:	n/a
39	chr5:37840158-37840208	AG09319	gingival:	n/a
40	chr5:37839918-37839968	GM19239	blood:	n/a
41	chr5:37840725-37840775	Hela-S3	cervix:	n/a
42	chr5:37840089-37840139	ProgFib	skin:	n/a
43	chr5:37838741-37838791	NHBE	bronchial:	n/a
44	chr5:37838741-37838791	HUVEC	blood vessel:	n/a
45	chr5:37840839-37840889	Hepatocyte	liver:	n/a
46	chr5:37839923-37839973	K562	blood:	n/a
47	chr5:37840158-37840208	HRPEpiC	eye:	n/a
48	chr5:37840089-37840139	ovcar-3	ovarian:	n/a
49	chr5:37839684-37839734	GM12891	blood:	n/a
50	chr5:37839918-37839968	HUVEC	blood vessel:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:37837605..37839454-chr5:37840945..37842875,2	K562	blood:
2	chr5:37837605..37839454-chr5:37840945..37842875,2	K562	blood:
3	chr5:37837099..37839105-chr5:37840105..37842875,2	K562	blood:
4	chr5:37840566..37843558-chr5:37850227..37851845,2	K562	blood:
5	chr5:37834038..37837439-chr5:37839505..37841588,3	MCF-7	breast:

(count:5 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-WDR70-1	chr5:37839970-37840675	NONHSAT101070
2	lnc-WDR70-1	chr5:37840540-37840675	ENSG00000248587.2
3	lnc-WDR70-1	chr5:37840631-37840675	XLOC_004341
4	lnc-WDR70-1	chr5:37841097-37841140	NONHSAT101070
5	lnc-WDR70-1	chr5:37840540-37840675	NR_103441

No data

Variant related genes	Relation type
GDNF	TF binding region
GDNF-AS1	TF binding region
GDNF	CpG island
GDNF-AS1	CpG island
ENSG00000248587	chromatin interactions
ENSG00000168621	chromatin interactions

Extended variants
information (count: 94 )
Associated
traits (count: 98 )

Variant overlapped rSNPs/rCNVs (count:94 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs557563198	chr5:37838761-37838762	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
2	rs372750924	chr5:37838768-37838769	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
3	rs571982732	chr5:37838785-37838786	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
4	rs112309485	chr5:37838839-37838840	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
5	rs116762089	chr5:37838847-37838848	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
6	rs369771948	chr5:37838857-37838858	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
7	rs543483079	chr5:37838894-37838895	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
8	rs139417981	chr5:37838917-37838918	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
9	rs114812377	chr5:37838922-37838923	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
10	rs564030967	chr5:37838991-37838992	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
11	rs541105752	chr5:37839013-37839014	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
12	rs537461451	chr5:37839027-37839028	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
13	rs192552463	chr5:37839074-37839075	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
14	rs546230069	chr5:37839089-37839090	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
15	rs533485645	chr5:37839111-37839112	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs72747316	chr5:37839135-37839136	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs555838594	chr5:37839178-37839179	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs146131946	chr5:37839192-37839193	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
19	rs563838857	chr5:37839205-37839206	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
20	rs12657011	chr5:37839270-37839271	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
21	rs567563441	chr5:37839273-37839274	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
22	rs549859215	chr5:37839279-37839280	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs184504628	chr5:37839314-37839315	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs2910699	chr5:37839330-37839331	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs528873832	chr5:37839384-37839385	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs190618774	chr5:37839408-37839409	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
27	rs111786815	chr5:37839414-37839415	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
28	rs117079497	chr5:37839416-37839417	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
29	rs568695583	chr5:37839446-37839447	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
30	rs539316228	chr5:37839532-37839533	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs557649270	chr5:37839568-37839569	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs569464916	chr5:37839590-37839591	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs536856799	chr5:37839616-37839617	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs2973034	chr5:37839618-37839619	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs2973033	chr5:37839633-37839634	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs574096655	chr5:37839684-37839685	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs554953764	chr5:37839794-37839795	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs541394883	chr5:37839875-37839876	Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs553127907	chr5:37839911-37839912	Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs577983188	chr5:37839946-37839947	Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs545689245	chr5:37839961-37839962	Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs563976552	chr5:37839974-37839975	Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
43	rs531089406	chr5:37839984-37839985	Bivalent/Poised TSS Flanking Active TSS Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
44	rs543286033	chr5:37840099-37840100	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
45	rs561743547	chr5:37840109-37840110	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
46	rs529011322	chr5:37840177-37840178	Bivalent/Poised TSS Flanking Active TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer	TF binding region CpG island Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
47	rs192595720	chr5:37840232-37840233	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
48	rs2075681	chr5:37840243-37840244	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
49	rs374694499	chr5:37840248-37840249	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a
50	rs184461513	chr5:37840253-37840254	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Enhancers Bivalent Enhancer	TF binding region Chromatin interactive region lncRNA	3 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:98)

Disease	PMID	Source
Myofibroblastic sarcoma	19369631	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Non-small cell lung cancer	20864512	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Multiple myeloma	17550852	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Cancer	16751803	CNVD
Breast cancer	16608533	CNVD
Autism	22495311	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Intellectual disability	22102821	CNVD
Prostate cancer	21965145	CNVD
Cancer	21183584	CNVD
Ovarian cancer	20844748	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Non-small cell lung cancer	19010865	CNVD
Glioblastoma multiforme	22286061	CNVD
Ovarian cancer	21720365	CNVD
Lung cancer	18438408	CNVD
Glioma	20126413	CNVD
Non-small cell lung cancer	21829676	CNVD
Breast cancer	22032731	CNVD
Esophageal cancer	20955586	CNVD
Prostate cancer	18632612	CNVD
Medulloblastoma	19270706	CNVD
Breast cancer	19553991	CNVD
Lung cancer	19553991	CNVD
Melanoma	19553991	CNVD
Ovarian cancer	19553991	CNVD
Prostate cancer	19553991	CNVD
Non-small cell lung cancer	17156491	CNVD
Breast cancer	17133270	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Breast cancer	17393978	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Acute lymphoblastic leukemia	17640729	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Lung cancer	19153074	CNVD
Cornelia de Lange syndrome	21085971	CNVD
Autism	21701786	CNVD
Cervical cancer	16585170	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Schizophrenia	19197363	CNVD

Chromatin state (count:439 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:37834200-37839000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
2	chr5:37834200-37841000	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
3	chr5:37834400-37838800	Active TSS	Colon Smooth Muscle	Colon
4	chr5:37834400-37840600	Bivalent Enhancer	Fetal Brain Male	brain
5	chr5:37834400-37841400	Bivalent/Poised TSS	Colonic Mucosa	Colon
6	chr5:37835000-37839800	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
7	chr5:37835800-37840000	Bivalent Enhancer	Spleen	Spleen
8	chr5:37836000-37839400	Bivalent/Poised TSS	Fetal Kidney	kidney
9	chr5:37836200-37839000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
10	chr5:37836200-37840200	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
11	chr5:37836200-37840600	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
12	chr5:37836200-37840800	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
13	chr5:37836200-37840800	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
14	chr5:37836200-37840800	Active TSS	NHDF-Ad	bronchial
15	chr5:37836200-37841000	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
16	chr5:37836200-37841000	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
17	chr5:37836400-37839600	Bivalent/Poised TSS	Brain Angular Gyrus	brain
18	chr5:37836400-37839600	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
19	chr5:37836400-37839800	Bivalent Enhancer	Primary B cells from peripheral blood	blood
20	chr5:37836400-37839800	Flanking Bivalent TSS/Enh	Fetal Muscle Trunk	muscle
21	chr5:37836400-37840600	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
22	chr5:37836400-37840600	Active TSS	HSMM	muscle
23	chr5:37836400-37840800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
24	chr5:37836400-37841200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
25	chr5:37836400-37841600	Active TSS	HSMMtube	muscle
26	chr5:37836600-37838800	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
27	chr5:37836600-37838800	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
28	chr5:37836600-37838800	Flanking Bivalent TSS/Enh	Fetal Intestine Large	intestine
29	chr5:37836600-37839000	Bivalent/Poised TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr5:37836600-37839000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
31	chr5:37836600-37839400	Active TSS	Aorta	Aorta
32	chr5:37836600-37839800	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
33	chr5:37836600-37839800	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
34	chr5:37836600-37840000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
35	chr5:37836600-37840000	Bivalent/Poised TSS	Rectal Mucosa Donor 31	rectum
36	chr5:37836600-37840200	Enhancers	Lung	lung
37	chr5:37836600-37841000	Flanking Active TSS	HMEC	breast
38	chr5:37836800-37838800	Flanking Bivalent TSS/Enh	Placenta	Placenta
39	chr5:37836800-37839400	Flanking Active TSS	Liver	Liver
40	chr5:37837000-37839200	Bivalent Enhancer	Primary T cells effector/memory enriched fromperipheralblood	blood
41	chr5:37837000-37840600	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
42	chr5:37837000-37840800	Active TSS	Osteobl	bone
43	chr5:37837200-37838800	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
44	chr5:37837200-37838800	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
45	chr5:37837400-37839200	Bivalent Enhancer	Fetal Heart	heart
46	chr5:37837400-37839600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
47	chr5:37837600-37838800	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
48	chr5:37837600-37839000	Active TSS	Right Ventricle	heart
49	chr5:37837600-37839200	Bivalent Enhancer	Primary T helper memory cells from peripheral blood 2	blood
50	chr5:37837800-37838800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links